Login
Toggle navigation
Videos
Categories
Trending
helping to craft the right mix of funds and individual investors for the round|Andy Dunn,Founder,Red Swan Ventures
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Co-founder and founder CEO of Bonobos (acquired by Walmart)
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
crypto and enterprise software companies across all stages|Corinne Marie Riley,Investor,Greylock
00:10:00
The impact of Covid-related travel disruptions, and Darrin’s views on the best and worst aspects of being a listed company|Darrin Grafton,CEO, Serko
00:10:00
investing in high potential B2B technology startups|Caroline Casson,Partner,VITALIZE Venture Capital
00:10:00
Bonds, Technology, and Global Markets: An In-Depth Discussion with PGIM CEO David Hunt | David Hunt, CEO , PGIM.
00:10:00
Hydrogen: Production Methods, Applications, and Value Chain Insights
00:10:00
Pennant International Group CEO Philip Walker Discusses Company's Transformation and Exciting Growth Prospects.
00:10:00
Navigating Multi-Strategy Investing: Insights from Edward Olanow of Weiss Multi-Strategy Advisers | Edward Olanow - Director of Investment Solutions & Portfolio Manager, Weiss Multi-Strategy Advisers
00:10:00
Expert.ai's CEO Walt Mayo provides an update on the company's FY20 results and discusses their ongoing technology development in a YouTube video by Edison, dated April 28, 2021.
00:10:00
Strategic Vision with Planning Alternatives' President Nathan Mersereau | Nathan Mersereau, President, Planning Alternatives Ltd.
00:10:00
President and CEO of CUC, Mr. Richard Hew, discusses reasons behind decisions and strategies at Caribbean Utilities Company Ltd.
00:10:00
Helps the daring build legendary companies|Jess Lee,Partner,Sequoia Capital
00:10:00
Jeremy Grantham Predicts S&P 500 to Plummet by Almost 50%: Insights from a Market Bubble Specialist | Jeremy Grantham , Co-Founder , GMO LLC.